Proposed Nasdaq symbol DICE. Business: Phase 1-ready biotech developing oral small molecule therapies for immunologic. Dutch Bros - Grants Pass, ...
News
- Initial public offerings scheduled to debut next week - mySA
- Proceeds from Quiros' settlement aim to help Newport recover - mySA
... Kelly were indicted criminally over a failed plan to build the biotechnology plant in Newport, using millions raised through the EB-5 program.
- South Africa jabs some children in test of Chinese vaccine - mySA
... as part of the global Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for children aged between 6 months and 17 years.
- The Latest: Biden calls out Republican governors on vaccines - MySA
... children and adolescents as part of the global Phase 3 clinical trials of China's Sinovac Biotech shot for children 6 months to 17 years.
- Advaxis: Fiscal Q3 Earnings Snapshot - MySA
The biotechnology company posted revenue of $250,000 in the period. The company's shares closed at 47 cents. A year ago, they were trading at 44 ...